Neurology News

PHILADELPHIA — Many patients with mild traumatic brain injury have central sensitization, a pain that requires a different therapeutic approach than nociceptic pain, according to a study by Christopher File, BSA, and colleagues.

Up to 25% of cancer survivors are affected by persistent symptoms of cognitive dysfunction.

PHILADELPHIA — Biomarkers are enabling the detection of neurological diseases up to 3 decades before a diagnosis would typically occur, Jane Paulsen, PhD FANA, says in this Healio video.

PHILADELPHIA — Better sleep boosts quality of life and may have positive long-reaching benefits including reduction of risk for neurological disorders, according to research presented at the American Neurological Association annual meeting.

Case-control and cohort analyses showed dysphasia, gastroparesis, irritable bowel syndrome without diarrhea and constipation may be associated with an increased risk for Parkinson’s disease, according to research in Gut.

Infection-specific processes, rather than general systemic inflammation, may play a role in the development of dementia among those with hospital-diagnosed infections, according to research from JAMA Network Open.

INDIANAPOLIS — Machine learning models predict the likelihood of type 1 narcolepsy with a high degree of accuracy, opening the door to increased access to testing and care, according to a speaker at SLEEP 2023.

Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.

A single dose of psilocybin resulted in clinically and statistically significant reductions in depressive symptoms and functional disability compared with placebo in patients with major depressive disorder, according to a phase 2 study.

A global clinical-stage specialty biopharmaceutical company has announced positive topline results from its study of its investigational therapeutic AM0-02 to treat children and adolescents with congenital myotonic dystrophy.